Insights from 2023 ESMO Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ESMO 2023 Insights: "ctDNA Reduction and Clinical Efficacy of the Darovasertib + Crizotinib Combination in Metastatic Uveal Melanoma"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Meredith McKean
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Meredith McKean
Comments 0
Login to view comments.
Click here to Login
